ELEric Chung Ching Leung

Eric Chung Ching Leung

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eric Chung Ching Leung has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Delayed diagnosis of tuberculosis: risk factors and effect on mortality among older adults in Hong Kong

    by Eric Cc Leung, Cc Leung, Kc Chang, Ck Chan, Thomas Yw Mok, Ks Chan, Ks Lau, Ch Chau, Wilson Ks Yee, Ws Law, et al.

    Objective: To assess the risk factors and effects of delayed diagnosis on tuberculosis (TB) mortality in Hong Kong. Methods: All consecutive patients with TB notified in 2010 were tracked through their clinical records for treatment outcome until 2012. All TB cases notified or confirmed after death were identified for a mortality survey on the timing and causes of death. Results: Of 5092 TB cases notified, 1061 (20.9%) died within 2 years of notification; 211 (4.1%) patients died before notification, 683 (13.4%) died within the first year, and 167 (3.3%) died within the second year after notification. Among the 211 cases with TB notified after death, only 30 were certified to have died from TB. However, 52 (24.6%) died from unspecified pneumonia/sepsis possibly related to pulmonary TB. If these cases are counted, the total TB-related deaths increases from 191 to 243. In 82 (33.7%) of these, TB was notified after death. Over 60% of cases in which TB was diagnosed after death involved patients aged 8() years and a similar proportion had an advance care directive against resuscitation or investigation. Independent factors for TB notified after death included female sex, living in an old age home, drug abuse, malignancy other than lung cancer, sputum TB smear negative, sputum TB culture positive, and chest X-ray not done. Conclusions: High mortality was observed among patients with TB aged 8() years. Increased vigilance is warranted to avoid delayed diagnosis and reduce the transmission risk, especially among elderly patients with co-morbidities living in old age homes.


  • Open Access

    Transmission of multidrug-resistant and extensively drug-resistant tuberculosis in a metropolitan city

    by Eric Chung Ching Leung, Chi Chiu Leung, Kai Man Kam, Wing Wai Yew, Kwok Chiu Chang, Wai Man Leung, Cheuk Ming Tam

    Multidrug-resistant (MDR)- tuberculosis (TB) and extensively drug resistant (XDR)-TB reportedly lead to increased household transmission.This is a retrospective cohort study of active TB occurring among household contacts exposed to MDR-TB.Of 704 contacts in 246 households, initial screening identified 12 (1.7%) TB cases (prevalent cases) and 17 (2.4%) contacts that subsequently developed active TB (secondary cases) after a median (range) duration of 17 (5–62.5) months. Eight prevalent cases and three secondary cases had MDR-TB. TB incidence rates per 100 000 person-years were 254.9 overall and 45.0 for MDR-TB. XDR-TB in the index MDR-TB patient significantly increased the odds of identifying a prevalent TB case to 4.8 (95% CI 1.02–22.5), and the hazard of finding a secondary TB case to 4.7 (95% CI 1.7–13.5). Molecular fingerprinting confirmed household transmission of MDR-TB. Of 20 retrievable isolates from 27 XDR-TB index cases, restriction fragment length polymorphism analysis showed clustering among 13 (65%), with 11 (55%) due to recent transmission by n-1 method and an identifiable household source in only three (27.2%) of the 11 cases.XDR-TB relative to MDR-TB significantly increases household transmission of TB, probably reflecting prolonged/higher infectivity, and indicating a need for prolonged household surveillance. XDR-TB may largely transmit outside of the household settings.


  • Shorter treatment duration for selected patients with multidrug-resistant tuberculosis: Table 1–

    by E.C.C. Leung, W.W. Yew, C.C. Leung, W.M. Leung, C.M. Tam

    To the Editors: Tuberculosis (TB) is still an infectious disease of public health importance today [1]. Of particular concern is the occurrence of multidrug-resistant (MDR)-TB with resistance to at least isoniazid and rifampicin, and extensively drug-resistant (XDR)-TB with additional resistance to any fluoroquinolone and at least one of the second-line injectable drugs, including kanamycin, amikacin and capreomycin. MDR- and XDR-TB need prolonged treatment duration, from 18 to 24 months after sputum culture conversion, as recommended by the World Health Organization (WHO) [2]. A prolonged duration of treatment may lead to poor adherence, higher cost and undue toxicity. In our previous studies, we found that the use of ofloxacin/levofloxacin-containing regimens had a favourable effect on MDR-TB outcome [3, 4]. Our studies also suggested that shorter treatment duration (mean duration 14 months) might be feasible in selected MDR-TB patients. Based on this finding, the treatment duration of selected MDR-TB patients under programmatic management in Hong Kong was changed from the rigid enforcement of ≥18 months after sputum conversion to an individualised duration tailored by the physician's judgement. The determinants favouring longer treatment included extensive drug resistance, delayed sputum culture conversion, greater extent of radiographic disease (including cavities), presence of diabetes or silicosis, and extrapulmonary disease. Out of these factors, the extent of drug resistance was the most important. Ofloxacin-resistant MDR-TB was arbitrarily given a prolonged treatment based on our previous studies [3, 4]. Despite a relatively high TB incidence (76 cases per 100,000 population in 2009), both TB and MDR-TB rates are actually decreasing under the local TB control programme [5]. Therefore, we conducted a retrospective evaluation of the long-term outcomes of our MDR-TB patients, focusing on the factors affecting the efficacy and relapse rate of a shorter treatment duration. …